↓ Skip to main content

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Citations

dimensions_citation
104 Dimensions

Readers on

mendeley
87 Mendeley